⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25388030 | 0.71 | — | — | |
| SCHEMBL1350357 | 0.71 | — | — | |
| SCHEMBL18433299 | 0.71 | — | — | |
| SCHEMBL961393 | 0.71 | — | — | |
| SCHEMBL1277245 | 0.67 | — | — | |
| SCHEMBL2960262 | 0.64 | — | — | |
| Hydrochloric Acid SCHEMBL28334923 | 0.64 | — | — | |
| SCHEMBL17873990 | 0.64 | — | — | |
| SCHEMBL2960259 | 0.64 | — | — | |
| SCHEMBL6909509 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104114171-A | Treatment of autoimmune disorders using RXR agonists | IO THERAPEUTICS INC | 2014-10-22 | — | — | CN | claimed |
| CN-101316583-A | Treatment of cancer with specific rxr agonists | VITAE PHARMACEUTICALS INC (US) | 2008-12-03 | — | — | CN | claimed |
| CN-1121379-C | Synthesis and use of retinoid having negative hormone and/or antagonist activity | ALLERGAN CO (US) | 2003-09-17 | — | — | CN | claimed |
| CN-1368975-A | Organosilyl compounds having nuclear hormone receptor modulating activity | ALLERGAN SALES INC (US) | 2002-09-11 | — | — | CN | claimed |
| CN-1360890-A | Use of active retiene derivative with negative hormone and/or antagonist | ALLERGAN INC (US) | 2002-07-31 | — | — | CN | claimed |
| CN-1211180-A | Method of treatment with compounds having RAG 'alpha' receptor specific or selective activity | ALLERGAN CO (US) | 1999-03-17 | — | — | CN | claimed |
| CN-1209802-A | Synthesis and use of retinoid having negative hormone and/or antagonist activity | ALLERGAN CO (US) | 1999-03-03 | — | — | CN | claimed |
| CN-1207727-A | Substd. aryl or heteroarylamides having retinoid-like biological activity | VISION PHARM LP (US) | 1999-02-10 | — | — | CN | claimed |
| CN-1056878-A | 2-substituted alkyl-3-carboxycarbapenems as antibiotics and process for their preparation | AMERICAN CYANAMID CO (US) | 1991-12-11 | — | — | CN | claimed |
| CN-110151745-A | Use the treatment of the autoimmune disorder of rxr agonist | IO治疗公司 | 2019-08-23 | — | — | CN | disclosed |
| CN-107861336-A | Red hardening resin composition, the colour filter formed by red hardening resin composition, the display device comprising colour filter | 东友精细化工有限公司 | 2018-03-30 | — | — | CN | disclosed |
| CN-107643653-A | Cyan hardening resin composition, colour filter and display device | 东友精细化工有限公司 | 2018-01-30 | — | — | CN | disclosed |
| CN-107004899-A | It is used as the ring-type phosphonic amide of the electrolyte component of lithium ion battery | 瓦克化学股份公司 | 2017-08-01 | — | — | CN | disclosed |
| CN-104114171-A | Treatment of autoimmune disorders using RXR agonists | IO THERAPEUTICS INC | 2014-10-22 | — | — | CN | disclosed |
| CN-1211180-A | Method of treatment with compounds having RAG 'alpha' receptor specific or selective activity | ALLERGAN CO (US) | 1999-03-17 | — | — | CN | disclosed |
| CN-1209802-A | Synthesis and use of retinoid having negative hormone and/or antagonist activity | ALLERGAN CO (US) | 1999-03-03 | — | — | CN | disclosed |
| CN-1207727-A | Substd. aryl or heteroarylamides having retinoid-like biological activity | VISION PHARM LP (US) | 1999-02-10 | — | — | CN | disclosed |
| CN-1108648-A | Novel 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them | AMERICAN CYANAMID CO (US) | 1995-09-20 | — | — | CN | disclosed |
| CN-1108649-A | Noel 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them | AMERICAN CYANAMID CO (US) | 1995-09-20 | — | — | CN | disclosed |
| CN-1056878-A | 2-substituted alkyl-3-carboxycarbapenems as antibiotics and process for their preparation | AMERICAN CYANAMID CO (US) | 1991-12-11 | — | — | CN | disclosed |